Videos

Eve Zaritsky, MD, reports that e-visits offer a safe, effective, and accessible option for patients seeking oral contraceptives.

Infants born to mothers in rural areas face greater odds of low Apgar scores and limited prenatal care access.

Ethan Lowder, BA, and Alexander Nagrebetsky, MD, MSc, reported that nearly 80% of children fast longer than recommended before surgery.

Carrie B. Hruska, PhD highlights how molecular breast imaging can reveal up to 2.5 times more invasive breast cancers than mammography alone.

Sarah Glynne, MBBS, BSc, and Jayant S. Vaidya, MD, FRCS, PhD, urge clinicians to move beyond blanket bans and support informed, patient-centered care.

Jayant S. Vaidya, MD, FRCS, PhD, and Sarah Glynne, MBBS, BSc, discuss new evidence challenging the blanket ban on HRT use after breast cancer.

New research highlights an increased risk of urinary incontinence following hysterectomy, underscoring the need for long-term management strategies.

As public uncertainty about vaccination during pregnancy grows, experts highlight the vital role of trusted health care providers in addressing hesitancy.

Rising childcare costs, limited access to daycare, and shifting generational attitudes are driving historic declines in US birth rates.

Experts discuss the future of healthcare, emphasizing innovative STI care, education, and the importance of collaboration in improving patient outcomes.

Panelists explore the future of STI screening and management, emphasizing the importance of guidelines and innovative diagnostics in women's health.

Discover how accessible STI testing and early detection enhance maternal-fetal health, reducing risks for mothers and newborns alike.

Innovations in diagnostic testing enhance patient care, empowering women with at-home options and faster access to essential health services.

Experts discuss the FDA's priority review of gepotidacin, an oral gonorrhea treatment, highlighting its potential to improve women's health and access to care.

Experts discuss updates in STI testing, congenital conditions, and best practices for pregnant women in this insightful healthcare panel.

A new analysis shows US births have fallen 22% since 2007, raising concerns about delayed childbearing and shrinking school enrollments.

In the 52-week OASIS-3 trial, elinzanetant significantly reduced the frequency and severity of hot flashes and night sweats.

Lariah M. Edwards, PhD, discusses how cost, accessibility, and inadequate policies limit women’s ability to reduce harmful chemical exposures.

Lariah M. Edwards, PhD, explains how avoiding risky ingredients in care products may lower health risks while highlighting the need for stronger safety regulations.

A study found that judicious prenatal opioid prescribing does not substantially increase the risk of autism or ADHD in children.

A study using objective Doppler measures shows that more active fetuses are associated with stronger maternal-fetal bonds.

New research suggests women with a history of cervical cancer face elevated anal cancer risk, highlighting the need for expanded screening guidelines.

New data reveal that more than 70% of Gen Z women report age-related fertility concerns, with experts urging education, proactive planning, and supportive language to reduce panic.

Jesus Gonzalez Bosquet, MD, PhD, discusses how machine learning could improve early ovarian cancer diagnosis by identifying methylated DNA in blood.

Uma Mahadevan, MD, explains updated international recommendations for inflammatory bowel disease in pregnancy.

A new study finds less than 16% of US counties offer vaginal birth after cesarean services, highlighting regional disparities.

Panelists discuss how the "if it's not broken, don't fix it" approach guides contraceptive continuation decisions, emphasizing the importance of directing patients to reliable online resources such as Bedsider.org to combat misinformation and support informed decision-making.

Panelists discuss how breakthrough bleeding affects approximately 20% of users initially but improves over time and can be managed through patient education about expectations, nonsteroidal anti-inflammatory drugs (NSAIDs) for acute episodes, and adjustments to estrogen dose or progestin type when necessary.

Panelists discuss how providers can utilize resources like Postpartum Support International for training, certification, and referrals, while building community networks and making warm handoffs to ensure patients receive appropriate care without barriers.